MAY 03, 2018 01:13 AM PDT

Re-Designing Treatments for Alzheimer Disease

WRITTEN BY: Nouran Amin

The most common form of dementia is Alzheimer which is a general term for memory loss and other cognitive abilities that complicate activities of daily life.

 

 

 

To this day, treating Alzheimer is difficult. However, new answers to why certain clinical trial drugs have failed to treat dementia and Alzheimer was explained in a study published in the journal Human Molecular Genetics. This study which was by scientists in Australia and the US, has provided new hope for potential new treatments with existing drugs.

 

In particular, investigators constructed evidence from human studies and animal models of dementia-related diseases to show that inflammation is a cause and not simply a consequence. Researchers provided evidence that many genes associated with dementia regulate our responses to the inflammatory damage.

"For decades, scientists have thought that dementia and Alzheimer's disease are caused by protein aggregates forming in the brain. But recent clinical trials of drugs that reduce the aggregates have failed," explains project leader Professor Robert Richards, from the University of Adelaide's School of Biological Sciences. Richards is collaborating with the University's Adelaide Medical School and the National Institutes of Health, in the US.

 

Inflammation was known to rise as a symptom of dementia-related diseases progression. However, now inflammation is believed to be a cause. Formerly, inflammation was studied as a way to “clean” tissue damage caused by protein aggregates. "We know that inflammation has different phases – early on it can be protective against a threat by actively degrading it, but if the threat is not removed, then persistent inflammation actually causes cell death," explains Professor Richards.

 

The research this implies that the genetic linkage allows inflammation to come comes first and then tissue damage second. "Many genes linked with dementia operate at the level of controlling cellular inflammation. Both internal and external triggers interact with these genes to play a part. Inflammation is the point through which many triggers converge," says Professor Richards who supports the idea that brain inflammation might as well be seen as a virus infection. "Inflammation is a very effective defense against foreign agents like viruses. But as we get older and accumulate mutations, our cells can make proteins and DNA products that mimic viruses, and these build up in the system," he further explains, "Normally, our cells bar-code their own products to tell them apart from foreign agents. When these bar-codes aren't in place, our cells can't properly distinguish 'self' and 'non-self' trigger molecules. The result is inflammation that escalates and spreads – hence the term auto-inflammatory disease." Eventually, these new insights can provide the basis for new drug discovery methods that will succeed. "With this new understanding of the disease, we now need to test existing anti-inflammatory drugs for their effectiveness in treating dementia".

 

Sources: MecialXpress.com, Alzheimer Association, Journal of Human Molecular Genetics

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 13, 2018
Drug Discovery
JUN 13, 2018
Psychedelics May Serve as Potential Treatment for Depression
Research at the University of California is examining the effect of hallucinogenic drugs on the brain and how this research can potentially provide some an...
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Identifying New Drug Targets in Therapy-Resistant Cancers
Recent research published in the Nature Partner journal Systems Biology and Applications examines how genome-wide data used in collaboration with systems b...
JUL 21, 2018
Genetics & Genomics
JUL 21, 2018
Designer Cells Sense & Destroy MRSA
Staphylococcus aureus is thought to lead to over 11 million visits to the doctor and the ER every year in the US alone....
AUG 27, 2018
Cardiology
AUG 27, 2018
Drug Reduces Deaths and Hospitalization from Heart Failure
New drug reduces deaths and hospitalization rates, while also improving quality of life, for patients with rare type of cardiomyopathy....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Drug Reduced Recurrent Ventricular Tachycardia
A common drug used to treat chest pain, known as ranolazine and branded as Ranexa®, was found to be safe in a clinical study of more than 1,000 patient...
SEP 24, 2018
Drug Discovery
SEP 24, 2018
Further Challenges in Alzheimer Drug Development
Scientists at Trinity College Dublin performed a large-scale international study involving the treatment of Alzheimer's disease, which was published in...
Loading Comments...